XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value of Assets and Liabilities (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
As of September 30, 2023 and December 31, 2022, the fair values of our derivative financial instrument and their classifications on the Condensed Consolidated Balance Sheets were as follows:


(in thousands)		Consolidated Balance Sheet ClassificationSeptember 30, 2023December 31, 2022
Derivatives Designated as Hedging Instruments
Interest rate swap agreement:
Designated as cash flow hedgePrepaid expenses and other current assets$4,963 $3,939 
Other long-term assets$6,533 $4,740 
Derivatives Not Designated as Hedging Instruments
Foreign exchange forward contractPrepaid expenses and other current assets$2,862 $6,186 
Schedule of Derivative Instruments Pre-tax Gains
The pre-tax (gains) losses recognized on derivative financial instruments in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and October 1, 2022 were as follows:
Three Months EndedNine Months Ended
(in thousands)Classification of (Gain) Loss Recognized in the
Condensed Consolidated Statements of Operations		September 30, 2023October 1, 2022September 30, 2023October 1, 2022
Derivatives designated as cash flow hedges
Interest rate swap agreementInterest expense, net$(1,252)$314 $(3,246)$335 
Derivatives Not Designated as Hedging Instruments
Foreign exchange forward contractForeign exchange loss$4,310 $3,209 $3,226 $3,209 


The pre-tax gains recognized on derivative financial instruments in the Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2023 and October 1, 2022 was as follows:
 Three Months EndedNine Months Ended
(in thousands)September 30, 2023October 1, 2022September 30, 2023October 1, 2022
Derivatives designated as cash flow hedges
Interest rate swap agreement$(2,034)$(10,012)$(2,817)$(9,300)
Schedule of Fair Value, Assets Measured on Recurring Basis
The following table presents assets measured at fair value by classification within the fair value hierarchy as of September 30, 2023:
 
 Fair Value Measurements Using 
(in thousands)Quoted Prices in
Active Markets for
Identical Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
Cash equivalents$427,671 $— $— $427,671 
Investments in equity securities9,703 — — 9,703 
Mutual funds18,192 — — 18,192 
   Total $455,566 $— $— $455,566 

The following table presents assets measured at fair value by classification within the fair value hierarchy as of December 31, 2022: 
 Fair Value Measurements Using 
(in thousands)Quoted Prices in
Active Markets for
Identical Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
Cash equivalents$304,101 $— $— $304,101 
Investments in equity securities10,653 — — 10,653 
Mutual funds14,094 — — 14,094 
   Total$328,848 $— $— $328,848 
Schedule of Fair Value, by Balance Sheet Grouping
The carrying value and estimated fair values of the Company’s Euro Senior Notes, Series A and Series B and USD Senior Notes, Series A and Series B, as of September 30, 2023 and December 31, 2022 were as follows:
 
 September 30, 2023December 31, 2022
(in thousands)Carrying
Value		Estimated
Fair Value		Carrying
Value		Estimated
Fair Value
Euro Senior Notes, Series A due 2023$123,605 $122,830 $124,716 $122,270 
Euro Senior Notes, Series B due 2028100,363 87,722 101,265 87,119 
USD Senior Notes, Series B due 2027100,000 92,866 100,000 93,764 
USD Senior Notes, Series A due 202550,000 48,338 50,000 48,145 
USD Senior Notes, Series B due 2030125,000 109,188 125,000 112,028 
USD Senior Notes, due 2032100,000 86,977 100,000 90,131